Logo

American Heart Association

  9
  0


Final ID:

Key Vascular Neurology Considerations for Anti-amyloid Immunotherapy (a Science Advisory)

  • Fisher, Mark  ( UNIVERSITY CA IRVINE , Orange , California , United States )
  • Greenberg, Steven  ( MGH , Boston , Massachusetts , United States )
  • Author Disclosures:
    Mark Fisher: DO NOT have relevant financial relationships | Steven Greenberg: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Bayer (Data Safety Committee):Active (exists now) ; Royalties/Patent Beneficiary:Up-To-Date:Active (exists now) ; Other (please indicate in the box next to the company name):Bristol Myers Squibb (Date Safety Committee):Active (exists now)
Meeting Info:
Session Info:

AHA Statements and Guidelines: A Year in Review

Thursday, 02/06/2025 , 03:30PM - 04:30PM

ISC Invited Symposium

More abstracts on this topic:
More abstracts from these authors:
Left Atrial Septal Pouch and Risk of Cryptogenic Stroke: A Systematic Review and Meta-Analysis

Xu Jennifer, Kang Jihoon, Schilling Jonathan, Paganini-hill Annlia, Kim Jin Kyung, Fisher Mark

A Neuroimmunology Framework to Diagnosing Inflammatory Vasculopathies

Agner Shannon, Greenberg Steven, Kharal Abbas

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)